Skip to main content

ORIGINAL RESEARCH article

Front. Pharmacol., 24 January 2019
Sec. Experimental Pharmacology and Drug Discovery
Volume 9 - 2018 | https://doi.org/10.3389/fphar.2018.01558
This article is part of the Research Topic Novel Targets and Biomarkers in Solid Tumors View all 32 articles

RETRACTED: DEAD-Box Helicase 5 Interacts With Transcription Factor 12 and Promotes the Progression of Osteosarcoma by Stimulating Cell Cycle Progression

Retracted

A retraction of this article was approved in:

  1. Retraction: DEAD-Box Helicase 5 Interacts With Transcription Factor 12 and Promotes the Progression of Osteosarcoma by Stimulating Cell Cycle Progression

    1. Read retraction
\r\nYanchun ChenYanchun Chen1Qiaozhen WangQiaozhen Wang2Qing WangQing Wang2Jinmeng LiuJinmeng Liu1Xin JiangXin Jiang1Yawen ZhangYawen Zhang1Yongxin LiuYongxin Liu3Fenghua ZhouFenghua Zhou4Huancai Liu*Huancai Liu5*
  • 1Department of Histology and Embryology, School of Clinical Medicine, Weifang Medical University, Weifang, China
  • 2Department of Human Anatomy, School of Clinical Medicine, Weifang Medical University, Weifang, China
  • 3Department of Anesthesiology, Weifang Medical University, Weifang, China
  • 4Department of Pathology, School of Clinical Medicine, Weifang Medical University, Weifang, China
  • 5Department of Joint Surgery, Affiliated Hospital, Weifang Medical University, Weifang, China

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Chen Y, Wang Q, Wang Q, Liu J, Jiang X, Zhang Y, Liu Y, Zhou F and Liu H (2019) DEAD-Box Helicase 5 Interacts With Transcription Factor 12 and Promotes the Progression of Osteosarcoma by Stimulating Cell Cycle Progression. Front. Pharmacol. 9:1558. doi: 10.3389/fphar.2018.01558

Received: 08 November 2018; Accepted: 21 December 2018;
Published: 24 January 2019; Retracted: 23 December 2019.

Edited by:

Dong-Hua Yang, St. John’s University, United States

Reviewed by:

Bo Tian, National Tsing Hua University, Taiwan
Yue-Li Sun, Guangdong Provincial People’s Hospital, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.